RxDoctor Payments Data

Loretta Duggan, MD

Family Medicine · Athens, GANPI 1376809665

Payments from drug & device makers

$561in general payments, 2019–2025

Across 23 payments — averaging $24.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$166
  • Myriad Genetic Laboratories, Inc.$97
  • Mayne Pharma Commercial LLC$88
  • AbbVie$69
  • Novo Nordisk$63
  • Boehringer Ingelheim$36
  • plus $42 from 3 others

What the payments were for

  • Food & beverage$561100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$561 in reported general payments places this provider in the 50th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$1,588
Medicare patients
28
Services billed
71

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin64$46,610
TrulicityDulaglutide30$33,638
MounjaroTirzepatide21$21,675
JanuviaSitagliptin Phosphate17$20,878
XareltoRivaroxaban17$19,769
OzempicSemaglutide14$18,715
EliquisApixaban12$14,915
Lantus SolostarInsulin Glargine,hum.Rec.Anlog47$7,818
Albuterol Sulfate HfaAlbuterol Sulfate58$1,244
Atorvastatin Calcium198$1,099
LantusInsulin Glargine,hum.Rec.Anlog18$1,093
Omeprazole88$1,059
Potassium Chloride63$979
Lisinopril147$716
Gabapentin51$693

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$166$55,31251 claims
Boehringer IngelheimJardiance$36$46,61064 claims
Novo NordiskOzempic$63$18,71514 claims
PfizerEliquis$14$14,91512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Athens

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →